Form 4 for PCVX Vaxcyte, Inc.
Accepted 2025-04-10 00:00:00 ET · period of report 2025-04-08 · accession 0001649094-25-000051 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-04-10 | 2025-04-08 | PCVX | Lukatch Heath | Dir | M - OptEx | $16.78 | +7,000 | 13.2K | +113% | +$117.5K |
| DM | 2025-04-10 | 2025-04-08 | PCVX | Lukatch Heath | Dir | M - OptEx | $0.00 | -7,000 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-04-08 | M | A | 1,000 | $21.49 | 14,175 | D | — | — | |
| 2 | Common | Common Stock | 2025-04-08 | M | A | 6,000 | $16.00 | 13,175 | D | — | — | |
| 3 | Derivative | Stock Option (right to buy) | 2025-04-08 | M | D | 1,000 | $0.00 | 14,000 | D | $21.49 · — to 2031-06-01 | 1,000 Common Stock | (F1) Fully vested and exercisable. |
| 4 | Derivative | Stock Option (right to buy) | 2025-04-08 | M | D | 6,000 | $0.00 | 0 | D | $16.00 · — to 2030-06-10 | 6,000 Common Stock | (F1) Fully vested and exercisable. |